Prevention of intraabdominal adhesions by local and systemic administration of immunosuppressive drugs

Iranian Red Crescent Medical Journal

Volumn 15, Issue 12, 2013, Pages

  Peker, Kemal ^a   Inal, Abdullah ^a   Sayar, Ilyas ^a   Sahin, Murat ^a   Gullu, Huriye ^a   Inal, Duriye Gul ^a   Isik, Arda ^a  

^a ERZINCAN UNIVERSITY   (Turkey)

Author keywords

General surgery; Immunosuppression; Peritoneum; Pharmaceutical preparations

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FIBROSIS; HISTOLOGY; HISTOPATHOLOGY; INFLAMMATION; LAPAROTOMY; MICROSCOPY; NONHUMAN; PERITONEAL CAVITY; PERITONEUM ADHESION; RAT; SCORING SYSTEM;

EID: 84888806309     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: 10.5812/ircmj.14148     Document Type: Article

References (27)

1. Restrepo C, Chacon J, Manjarres G. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. Perit Dial Int. 2010;30(6):619-25.
2. Du X, Hong G, Sun P, Liu G. Zn2+-SCMC versus HA for preventing intraperitoneal adhesions: a rat model study. Int J Med Sci. 2012;9(6):467-71.
3. Kossi JA, Salminen PT, Laato MK. Surgical workload and cost of postoperative adhesion-related intestinal obstruction: importance of previous surgery. World J Surg. 2004;28(7):666-70.
4. Burnett SH, Beus BJ, Avdiushko R, Qualls J, Kaplan AM, Cohen DA. Development of peritoneal adhesions in macrophage depleted mice. J Surg Res. 2006;131(2):296-301.
5. Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg. 2001;18(4):260-73.
6. Cheong YC, Laird SM, Li TC, Shelton JB, Ledger WL, Cooke ID. Peritoneal healing and adhesion formation/reformation. Hum Reprod Update. 2001;7(6):556-66.
7. Sulaiman H, Dawson L, Laurent GJ, Bellingan GJ, Herrick SE. Role of plasminogen activators in peritoneal adhesion formation. Biochem Soc Trans. 2002;30(2):126-31.
8. Yang B, Gong C, Zhao X, Zhou S, Li Z, Qi X, et al. Preventing postoperative abdominal adhesions in a rat model with PEG-PCL-PEG hydrogel. Int J Nanomedicine. 2012;7:547-57.
9. Kato T, Ruiz P, Thompson JF, Eskind LB, Weppler D, Khan FA, et al. Intestinal and multivisceral transplantation. World J Surg. 2002;26(2):226-37.
10. Sugitani A, Gritsch HA, Shapiro R, Bonham CA, Egidi MF, Corry RJ. Surgical Complications in 123 Consecutive Pancreas Transplant Recipients: Comparison of Bladder and Enteric Drainage. Transplantation proceedings. 1998;30(2):293-294.
11. Blachar A, Federle MP. Bowel obstruction following liver transplantation: clinical and ct findings in 48 cases with emphasis on internal hernia. Radiology. 2001;218(2):384-8.
12. Irkorucu O, Ferahkose Z, Memis L, Ekinci O, Akin M. Reduction of postsurgical adhesions in a rat model: a comparative study. Clinics (Sao Paulo). 2009;64(2):143-8.
13. Kaptanoglu L, Kucuk HF, Yegenoglu A, Uzun H, Eser M, Mentes CV, et al. Effects of seprafilm and heparin in combination on intra-abdominal adhesions. Eur Surg Res. 2008;41(2):203-7.
14. Kesting MR, Loeffelbein DJ, Steinstraesser L, Muecke T, Demtroeder C, Sommerer F, et al. Cryopreserved human amniotic membrane for soft tissue repair in rats. Ann Plast Surg. 2008;60(6):684-91.
15. Hellebrekers BW, Trimbos-Kemper GC, van Blitterswijk CA, Bakkum EA, Trimbos JB. Effects of five different barrier materials on postsurgical adhesion formation in the rat. Hum Reprod. 2000;15(6):1358-63.
16. Chung DR, Chitnis T, Panzo RJ, Kasper DL, Sayegh MH, Tzianabos AO. CD4+ T cells regulate surgical and postinfectious adhesion formation. J Exp Med. 2002;195(11):1471-8.
17. Chegini N. Peritoneal molecular environment, adhesion formation and clinical implication. Front Biosci. 2002;7:e91-115.
18. Falk K, Bjorquist P, Stromqvist M, Holmdahl L. Reduction of experimental adhesion formation by inhibition of plasminogen activator inhibitor type 1. Br J Surg. 2001;88(2):286-9.
19. Kansu E. Immünosüpressif Ajanlari{dotless}n Genel Özellikleri ve Etki mekanizmalari{dotless}. Ankem Dergisi. 2002;16(3):194-198.
20. Horowitz MM, Przepiorka D, Bartels P, Buell DN, Zhang MJ, Fitzsimmons WE, et al. Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine. Biol Blood Marrow Transplant. 1999;5(3):180-6.
21. Nakajima K, Ochiai T, Nagata M, Suzuki T, Gunji Y, Asano T, et al. Effects of triple therapy of cyclosporine, FK 506, and RS-61443 on allogeneic small bowel transplantation in dogs. Transplant Proc. 1993;25(1 Pt 1):595-6.
22. McMurray RW, Harisdangkul V. Mycophenolate mofetil: selective T cell inhibition. Am J Med Sci. 2002;323(4):194-6.
23. Allison Anthony C, Eugui Elsie M. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 2000;47(2-3):85-118.
24. Wasserberg N, Nunoo-Mensah JW, Ruiz P, Tzakis AG. The effect of immunosuppression on peritoneal adhesions formation after small bowel transplantation in rats. J Surg Res. 2007;141(2):294-8.
25. Allison AC. Mechanisms of action of mycophenolate mofetil. Lupus. 2005;14 Suppl 1:s2-8.
26. Kanko M, Ozbudak E, Ozerdem A, Aksoy A, Kilic M, Berki KT. Effect of sirolimus in the prevention of adhesions around intraabdominal prosthetic graft. World J Surg. 2006;30(9):1648-52.
27. Maciver AH, McCall MD, Edgar RL, Thiesen AL, Bigam DL, Churchill TA, et al. Sirolimus drug-eluting, hydrogel-impregnated polypropylene mesh reduces intra-abdominal adhesion formation in a mouse model. Surgery. 2011;150(5):907-15.